McCracken Joseph S
SEC insider (Form 3/4/5 filer). CIK 0001632454. Director at Savara Inc (SVRA) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 16, 2026. Located in LANGHORNE, PA.
Companies McCracken Joseph S has filed insider reports for
- Savara Inc (SVRA): Director
- LUMOS PHARMA, INC. ((LUMO)): Director
McCracken Joseph S
CIK: 0001632454
Transaction Breakdown
Open Market Buys (P)2 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (16.7%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (16.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 16, 2026SVRA
Savara Inc
ExerciseDirect1.8K shares at avg. $1.76$3K - Dec 9, 2025SVRA
Savara Inc
AwardDirect40K shares- - May 29, 2025SVRA
Savara Inc
PurchaseDirect10K shares at avg. $2.08$21K - Dec 12, 2024SVRA
Savara Inc
AwardDirect40K shares- - Dec 12, 2024(LUMO)
LUMOS PHARMA, INC.
DispositionDirect15.7K shares- - Nov 19, 2024SVRA
Savara Inc
PurchaseDirect20K shares at avg. $2.95$59K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 16, 2026 |  SVRA Savara Inc | Exercise | 1,807 | $1.76 | $3,180 | Direct |
| Dec 9, 2025 | SVRA Savara Inc | Award | 40,000 | - | - | Direct |
| May 29, 2025 | SVRA Savara Inc | Purchase | 10,000 | $2.08 | $20,825 | Direct |
| Dec 12, 2024 | SVRA Savara Inc | Award | 40,000 | - | $0 | Direct |
| Dec 12, 2024 | /logo?size=32) (LUMO) LUMOS PHARMA, INC. | Disposition | 15,721 | - | $0 | Direct |
| Nov 19, 2024 | SVRA Savara Inc | Purchase | 20,000 | $2.95 | $59,072 | Direct |
1-6 of 6 transactions